NDC 0069-0707-37 - Exubera

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC: 0069-0707
Requested NDC: 0069-0707-37
Package NDCs from labels: 0069-0707-37
Manufacturer: Pfizer Inc.
Effective date: 2008-04-08
Current FDA listing: Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
Label	Manufacturer	Effective date	Type
EXUBERA ® (insulin human [rDNA origin]) Inhalation Powder EXUBERA ® Inhaler	Pfizer Inc.	2008-04-08	HUMAN PRESCRIPTION DRUG LABEL

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
0069-0707-37	Exubera	90 in 1 PACKAGE	AEROSOL, POWDER	90		1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
0069-0707	EXUBERA (INSULIN HUMAN) EXUBERA (INSULIN HUMAN) AEROSOL, POWDER [PFIZER INC.]	1	1 package rows	20080418_4E25A881-DFC3-44A2-9EDE-49F7443776D8.zip

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
insulin human	ACTIVE INGREDIENT	1Y17CTI5SR	EXUBERA (INSULIN HUMAN) EXUBERA (INSULIN HUMAN) AEROSOL, POWDER [PFIZER INC.]	1
insulin human	ACTIVE MOIETY	1Y17CTI5SR	EXUBERA (INSULIN HUMAN) EXUBERA (INSULIN HUMAN) AEROSOL, POWDER [PFIZER INC.]	1
glycine	INACTIVE INGREDIENT	TE7660XO1C	EXUBERA (INSULIN HUMAN) EXUBERA (INSULIN HUMAN) AEROSOL, POWDER [PFIZER INC.]	1
mannitol	INACTIVE INGREDIENT	3OWL53L36A	EXUBERA (INSULIN HUMAN) EXUBERA (INSULIN HUMAN) AEROSOL, POWDER [PFIZER INC.]	1
sodium citrate	INACTIVE INGREDIENT	1Q73Q2JULR	EXUBERA (INSULIN HUMAN) EXUBERA (INSULIN HUMAN) AEROSOL, POWDER [PFIZER INC.]	1
sodium hydroxide	INACTIVE INGREDIENT	55X04QC32I	EXUBERA (INSULIN HUMAN) EXUBERA (INSULIN HUMAN) AEROSOL, POWDER [PFIZER INC.]	1

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 10 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Mannitol	MANNITOL	Hospira, Inc.	8ad3145e-00e7-4412-b9a5-06f00f264f30	2026-04-21	Warnings, Adverse reactions	Name fallback brand name: Mannitol
Mannitol	MANNITOL	ProPharma Distribution	430669d7-9ad1-9a04-e063-6394a90ababb	2025-11-07	Warnings, Adverse reactions	Name fallback brand name: Mannitol
Mannitol	MANNITOL	ICU Medical Inc.	ba7bf864-8a4d-4262-8fd1-00174fa2f9d1	2025-10-24	Warnings, Adverse reactions	Name fallback brand name: Mannitol
Glycine	GLYCINE	ICU Medical Inc.	c10a4657-cf64-4a71-a247-363dd58993bc	2025-10-21	Warnings, Adverse reactions	Name fallback brand name: Glycine
Mannitol	MANNITOL	Henry Schein, Inc.	e2444db1-9dfe-451f-a33c-9b00786464d2	2025-05-20	Warnings, Adverse reactions	Name fallback brand name: Mannitol
MANNITOL	MANNITOL	HF Acquisition Co LLC, DBA HealthFirst	999ce711-2d5b-0d7d-e053-2995a90a2689	2024-01-27	Warnings, Adverse reactions	Name fallback brand name: MANNITOL
Mannitol	MANNITOL	B. Braun Medical Inc.	d12cc802-b538-4065-a264-f474ff3b3043	2023-08-15	Warnings, Adverse reactions	Name fallback brand name: Mannitol
Mannitol	MANNITOL	Fresenius Kabi USA, LLC	c395e13d-6ea1-4104-8b37-669cfb982f04	2023-03-16	Warnings, Adverse reactions	Name fallback brand name: Mannitol
Glycine	GLYCINE	B. Braun Medical Inc.	f4d83550-42de-44c7-b8d5-1d0debc6aec2	2021-04-01	Warnings, Adverse reactions	Name fallback brand name: Glycine
Glycine	GLYCINE	Baxter Healthcare Corporation	d4665408-04d8-4ad7-8589-708d4defb869	2018-01-02	Warnings, Adverse reactions	Name fallback brand name: Glycine

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.